The Minimally Invasive Vertebral Compression Fracture Treatment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Minimally Invasive Vertebral Compression Fracture Treatment Market:
According to The Business Research Company’s Minimally Invasive Vertebral Compression Fracture Treatment Global Market Report 2024, The minimally invasive vertebral compression fracture treatment market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growing awareness and education, emerging markets, advancements in imaging technologies, increasing investment in research and development, supportive regulatory frameworks. Major trends in the forecast period include product innovations, strategic partnerships, technological advancements.
The rising prevalence of osteoporosis is expected to propel the growth of the minimally invasive vertebral compression fracture treatment market going forward. Osteoporosis is a medical disorder that weakens bones, increasing the risk of fractures and causing a decrease in bone density. The use of minimally invasive vertebral compression fracture treatments in osteoporosis reflects an advanced and effective approach to managing fractures, aiming to enhance patient outcomes and well-being. For instance, In December 2023, according to a report published by the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, osteoporosis contributed to 2,366 deaths, or 6.5 deaths per 100,000 population in 2021, representing 1.4% of all deaths. Further, in 2021–22, there were 9,500 hospitalizations with a principal diagnosis of osteoporosis (89 hospitalizations per 100,000 population) for people aged 45 and over. Therefore, the rising prevalence of osteoporosis is driving the growth of the minimally invasive vertebral compression fracture treatment market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13881&type=smp
The minimally invasive vertebral compression fracture treatment market covered in this report is segmented –
1) By Surgery: Minimally Invasive Spine Surgery, Open Spine Surgery
2) By Technology: Balloon Kyphoplasty, Vertebroplasty
3) By End-User: Hospitals, Ambulatory Surgery Centers (ASCs)
Major companies operating in the minimally invasive vertebral compression fracture treatment market focus on developing advanced technologies, such as access retractor systems, to serve customers better with advanced features. Minimally invasive access retractor systems are medical devices designed to facilitate less invasive surgical procedures by providing access to target areas with minimal tissue disruption, typically through small incisions or natural body openings. For instance, in April 2023, Orthofix Medical Inc., a US-based medical device company, launched two access retractor systems to assist surgeons in minimally invasive spine (MIS) procedures. The Lattus Lateral Access System and Fathom Pedicle-Based Retractor System enhance the company’s access solutions. The Lattus system offers ease of use and versatility, independent blade retraction strength, and a unique down-and-out splay feature for challenging anatomy access. The Fathom Retractor, featuring three points of active telescoping blade fixation, allows surgeons to customize lateral to medial tilt for a precise and rigid construct, promoting optimal outcomes in MIS procedures. Both systems enhance surgical workflow, improve visualization, and complement Orthofix’s comprehensive procedural solutions.
The minimally invasive vertebral compression fracture treatment market report table of contents includes:
1. Executive Summary
2. Minimally Invasive Vertebral Compression Fracture Treatment Market Characteristics
3. Minimally Invasive Vertebral Compression Fracture Treatment Market Trends And Strategies
4. Minimally Invasive Vertebral Compression Fracture Treatment Market – Macro Economic Scenario
5. Global Minimally Invasive Vertebral Compression Fracture Treatment Market Size and Growth
.
.
.
26. South America Minimally Invasive Vertebral Compression Fracture Treatment Market
27. Brazil Minimally Invasive Vertebral Compression Fracture Treatment Market
28. Middle East Minimally Invasive Vertebral Compression Fracture Treatment Market
29. Africa Minimally Invasive Vertebral Compression Fracture Treatment Market
30. Minimally Invasive Vertebral Compression Fracture Treatment Market Competitive Landscape AndCompany Profiles
Top Major Players:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Streaming media devices refer to hardware that allows music and video to…
Overview and Scope Smart harvest refers to the use of advanced technologies, such as machine…
Overview and Scope Sheet metal refers to a thin, lightweight, high-strength, flat sheet made up…
Overview and Scope The vertical lift module (VLM) refers to a vertical automated storage and…
Overview and Scope Vanilla extract is a liquid flavor made from a vanilla bean that…
Overview and Scope Vaginitis therapeutics refers to the use of the drugs such as antifungal…